Direct and selective factor Xa inhibitor (apixaban).
Selective thrombin inhibitor (dabigatran); antidote: idarucizumab can reverse the effect of the oral anticoagulant dabigatran within minutes; bleeding stops within 2.5 hours-but there may be a rebound in bleeding times after 12 to 24 hours, leading to rebleeding in some patients.
Antiplatelet agents (abciximab, acetylsalicylic acid (ASA), combination of acetylsalicylic acid and dipyridamole, clopidogrel, eptifibatide, ilomedin (prostacyclin analog), prasugrel, ticagrelor, ticlopidine, tirofiban)Low-dose (up to 300 mg/day) continuous medication with acetylsalicylic acid (ASA; Antiplatelet agents), as prescribed in the primary and secondary prevention of vascular events, does not increase the risk of intracranial hemorrhage.
Fibrinolytics (drugs used for the acute treatment of conditions caused by vascular occlusion; they cause the blood clot to dissolve).